EN
Introduction to Liquid-Based Cytology Device
An Liquid-Based Cytology Device is a medical device used to prepare samples for cytological examination. It processes cells collected from various body sites (e.g., cervix, lungs) and suspends them in a liquid medium, which is then used to create a thin, uniform layer of cells on a microscope slide for analysis.
Application of Liquid-based cytology devices
Gynecological
Liquid-based cytology devices are crucial for cervical cancer screening. By collecting exfoliated cells from the cervix, creating thin-layer cell slides, and observing cell morphology and structure under a microscope, one can determine the presence of abnormal cells, such as precancerous lesions or cancer cells.
Sputum
Sputum cytology examination is an important method for diagnosing respiratory diseases. By collecting a sputum sample from the patient and examining the cells, abnormalities such as cancer cells and inflammatory cells can be detected. Liquid-based cytology devices are also suitable for sputum cytology, improving cell detection rates and diagnostic accuracy, thereby providing strong support for the diagnosis and treatment of respiratory diseases.
Urine
Urine cytology examination is primarily used to diagnose urinary system diseases. By collecting a urine sample from the patient and examining the cells, abnormal cells in the urine, such as cancer cells and transitional epithelial cells, can be detected. The application of liquid-based cytology devices in urine cytology can improve cell detection rates and diagnostic accuracy, thereby aiding in the diagnosis and treatment of urinary system diseases.
Serous Effusion
Serous effusion refers to abnormal fluid accumulation in body cavities (pleural, peritoneal, pericardial). Cytopathological analysis aims to determine its cause—transudative (systemic factors, e.g., heart failure) or exudative (local inflammation or malignancy). Benign effusions show reactive mesothelial cells, lymphocytes, or neutrophils, with uniform morphology. Malignant effusions display cellular atypia (pleomorphism, high nuclear-to-cytoplasmic ratio, irregular nuclei) and clusters, often indicating metastatic adenocarcinoma (e.g., lung, breast) or primary mesothelioma/lymphoma. Ancillary techniques (immunocytochemistry, flow cytometry) aid differentiation, particularly between mesothelioma and adenocarcinoma. Cytology confirms malignancy (stage IV cancer) or identifies infections (e.g., tuberculosis). Using liquid-based cytology devices can improve cell detection rates and diagnostic accuracy.
Fine needle aspiration (FNA)
Fine Needle Aspiration (FNA) is a minimally invasive and cost-effective procedure used to obtain cellular samples from palpable or imaging-guided lesions, such as thyroid nodules, breast masses, and lymph nodes. The primary goal of Fine Needle Aspiration Cytology (FNAC)—the laboratory analysis of these samples—is to determine whether the observed cellular features are consistent with normal, benign conditions (e.g., cysts, inflammatory processes) or suggest malignant changes (e.g., carcinomas, lymphomas). This diagnostic technique is crucial in distinguishing between benign and malignant lesions, guiding further clinical management.
Advantages of HealthSky Liquid-based cytology device
The HealthSky liquid-based cytology device uses the most advanced liquid-based technology. By evenly dispersing cells and removing blood and mucus, it ensures high-quality sample preparation.
The HealthSky liquid-based cytology device provides clearer and more reliable slides, aiding in the detection of abnormal cells, including precancerous and cancerous lesions.
The HealthSky liquid-based cytology device features a user-friendly interface, automated processing, and robust quality control functions. This simplifies laboratory workflows, reduces human error, and improves patient treatment outcomes.
